rs756408696
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000335473.12(MYO18B):βc.6660_6670delβ(p.Arg2220SerfsTer74) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,613,568 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.000020 ( 0 hom., cov: 32)
Exomes π: 0.00015 ( 0 hom. )
Consequence
MYO18B
ENST00000335473.12 frameshift
ENST00000335473.12 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.40
Genes affected
MYO18B (HGNC:18150): (myosin XVIIIB) The protein encoded by this gene may regulate muscle-specific genes when in the nucleus and may influence intracellular trafficking when in the cytoplasm. The encoded protein functions as a homodimer and may interact with F actin. Mutations in this gene are associated with lung cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-26026632-AGATTAGAACCT-A is Pathogenic according to our data. Variant chr22-26026632-AGATTAGAACCT-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 590293.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO18B | NM_032608.7 | c.6660_6670del | p.Arg2220SerfsTer74 | frameshift_variant | 43/44 | ENST00000335473.12 | NP_115997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO18B | ENST00000335473.12 | c.6660_6670del | p.Arg2220SerfsTer74 | frameshift_variant | 43/44 | 1 | NM_032608.7 | ENSP00000334563 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151914Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151914
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000442 AC: 11AN: 248956Hom.: 0 AF XY: 0.0000444 AC XY: 6AN XY: 135148
GnomAD3 exomes
AF:
AC:
11
AN:
248956
Hom.:
AF XY:
AC XY:
6
AN XY:
135148
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000154 AC: 225AN: 1461654Hom.: 0 AF XY: 0.000161 AC XY: 117AN XY: 727118
GnomAD4 exome
AF:
AC:
225
AN:
1461654
Hom.:
AF XY:
AC XY:
117
AN XY:
727118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151914Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74178
GnomAD4 genome
AF:
AC:
3
AN:
151914
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74178
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome Pathogenic:4
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 13, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 27, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine, Nationwide Children's Hospital | Oct 10, 2018 | This individual is compound heterozygous for two likely pathogenic changes in the MYO18B gene. These frameshift alterations encode a premature stop of translation (ACMG: PVS1). The first, p.Arg2220SerfsTer74, occurs at an amino acid position 86% of the way through the full length protein, and the second, p.Leu2257SerfsTer16, occurs 88% of the way through the full length protein. These alterations occur within exon 43 of the transcript, NM_032608.5, within the penultimate exon of the gene (also representing the final coding exon of the transcript). These variants are very rare (p.Arg2220SerfsTer74) or absent (p.Leu2257SerfsTer16) from population databases (gnomAD) (ACMG: PM2). MYO18B is associated with autosomal recessive Klippel-Feil syndrome-4 with nemaline myopathy and facial dysmorphism (OMIM: 616549). Limited phenotypic data have been described in the literature and medical databases, however MYO18B variants encoding a premature stop of translation have been previously documented in association with myopathy, mild short stature, microcephaly, cardiomyopathy, pectus deformity, digit anomalies and distinctive facies (PMID: 25748484; 27858739). Characterization of the effect of a premature stop of translation within MYO18B has been described in the setting of in-vitro analyses. Examination of an affected patient's lymphocytes harboring a nonsense alteration (p.Ser2303Ter) demonstrated markedly diminished MYO18B transcript by quantitative PCR in comparison to a control, therefore hypothesized to be consistent with nonsense-mediated decay (PMID: 25748484). Moreover, western blot analysis and immunostaining of skeletal muscle in another patient harboring a nonsense alteration (p.Glu2166Ter) demonstrated the absence of the C-terminus of the protein hypothesized to be consistent with protein truncation (PMID: 27858739). - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Sep 08, 2021 | This sequence variant is an 11 base pair deletion in exon 43 of the Myosin 18B protein and results in an early termition codon 74 amino acids downstream of the frameshift at Arg2220. This variant is predicted to generate a non-functiol allele through either the expression of a truncated protein or a loss of MYO18 expression due to nonsense mediated decay. This is a previously reported variant (ClinVar) that is rare in control population datasets (gnomAD database, 11/248956 alleles or 0.004%). This variant has been observed in an individual with MYO18B-related disease and was a compound heterozygote for a second truncating variant in MYO18 (PMID: 31195167). Given the evidence we consider this variant to be likely pathogenic. ACMG Criteria: PM2, PVS1 - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 01, 2023 | This sequence change creates a premature translational stop signal (p.Arg2220Serfs*74) in the MYO18B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO18B are known to be pathogenic (PMID: 25748484, 32184166, 32637634). This variant is present in population databases (rs756408696, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Klippel-Feil syndrome (PMID: 31195167, 33179433). ClinVar contains an entry for this variant (Variation ID: 590293). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2024 | Frameshift variant predicted to result in abnormal protein length as the last 348 amino acids are replaced with 73 different amino acids, and other similar variants have been reported in HGMD; This variant is associated with the following publications: (PMID: 32278351, 32184166, 33179433, 31195167) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at